Literature DB >> 1896812

High prevalence of autoimmune liver disease in patients with multiple nuclear dot, anti-centromere, and mitotic spindle antibodies.

B U Hansen1, S Eriksson, S Lindgren.   

Abstract

We used HEp-2 cells to compare the occurrence of multiple nuclear dot (MND), anti-centromere (ACA), and mitotic spindle antibodies (MSA) in patients with primary biliary cirrhosis (PBC) (n = 32) and primary Sjögren's syndrome (n = 50). The predictive value of these antibodies for autoimmune liver disease was evaluated among patients with chronic liver or inflammatory connective tissue diseases. MND were found in 6%, ACA in 10%, and MSA in 6% of PBC sera. Among patients with primary Sjögren's syndrome, ACA were found in one, whereas another had both MND and MSA. MND were also detected in 1 of 25 sera from patients with other chronic inflammatory connective tissue diseases. Reexamination of these three patients showed evidence of PBC in two. In a blinded study of sera from 356 patients with chronic liver diseases, MND were detected in 10 (3%), ACA in 2 (0.9%), and MSA in 4 (1.2%). All patients with MND or ACA and two of four with MSA had PBC or autoimmune chronic active hepatitis, particularly of the cholestatic type. In four of these patients the liver disease had not previously been classified. We conclude that these antibodies have low sensitivity but high predictive value for autoimmune, cholestatic liver disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1896812     DOI: 10.3109/00365529108998588

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  9 in total

Review 1.  Autoantibodies as prognostic markers in autoimmune liver disease.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-05-13       Impact factor: 3.199

2.  Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis.

Authors:  C Rigamonti; L M Shand; M Feudjo; C C Bunn; C M Black; C P Denton; A K Burroughs
Journal:  Gut       Date:  2005-09-08       Impact factor: 23.059

3.  Autoantibodies to mitotic apparatus: association with other autoantibodies and their clinical significance.

Authors:  Branka Bonaci-Nikolic; Sladjana Andrejevic; Mirjana Bukilica; Ivana Urosevic; Milos Nikolic
Journal:  J Clin Immunol       Date:  2006-08-29       Impact factor: 8.317

Review 4.  Pathogenesis of primary biliary cirrhosis.

Authors:  David E J Jones
Journal:  Gut       Date:  2007-07-19       Impact factor: 23.059

5.  Anti-Mitotic Spindle Apparatus Antoantibodies: Prevalence and Disease Association in Chinese Population.

Authors:  Qian Xi; Yongkang Wu; Lixin Li; Bei Cai; Junlong Zhang; Bin Yang; Lanlan Wang
Journal:  J Clin Lab Anal       Date:  2016-03-14       Impact factor: 2.352

6.  Primary biliary cirrhosis sera recognize not only gp210 but also proteins of the p62 complex bearing N-acetylglucosamine residues from rat liver nuclear envelope. Anti-p62 complex antibody in PBC.

Authors:  K Miyachi; M Shibata; Y Onozuka; F Kikuchi; N Imai; T Horigome
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

7.  Antibodies to mitotic spindle apparatus: clinical significance of NuMA and HsEg5 autoantibodies.

Authors:  Lourdes Mozo; Carmen Gutiérrez; Jesús Gómez
Journal:  J Clin Immunol       Date:  2008-02-01       Impact factor: 8.317

8.  Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges.

Authors:  Cristina Rigamonti; Dimitrios P Bogdanos; Maria G Mytilinaiou; Daniel S Smyk; Eirini I Rigopoulou; Andrew K Burroughs
Journal:  Int J Rheumatol       Date:  2011-12-06

Review 9.  Extrahepatic Manifestations of Primary Biliary Cholangitis.

Authors:  Sara L Chalifoux; Peter G Konyn; Gina Choi; Sammy Saab
Journal:  Gut Liver       Date:  2017-11-15       Impact factor: 4.519

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.